FIELD: pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics, namely to a pharmaceutical combination for the treatment of solid tumor, containing: a) effective amount of the first pharmaceutical compositions containing 3-(5-amino-2-(4-(2-(3,3-difluor-3-phosphonopropoxy)ethoxy)-2-methylphenethyl)benzo[f][1,7]naphthyridine-8-yl)propanoic acid or its pharmaceutically acceptable salt, aluminum-containing particles, a buffer agent, and one or several pharmaceutically acceptable auxiliary substances, where the buffer agent is tris-buffer; pharmaceutically acceptable auxiliary substance is mannitol; the composition has pH in the range from 6.5 to 9.0, and aluminum-containing particles are a suspension of aluminum hydroxide particles, and b) effective amount of the second pharmaceutical composition containing an antibody to PD-L1. The invention also relates to a pharmaceutical combination for the treatment of solid tumor, such as defined above, additionally containing c) effective amount of the third pharmaceutical composition containing an antibody to CTLA-4.
EFFECT: effective treatment of solid tumors.
7 cl, 10 dwg, 17 tbl, 15 ex
Title |
Year |
Author |
Number |
IL-10/FC FUSION PROTEINS SUITABLE AS IMMUNOTHERAPY ENHANCERS |
2020 |
- Go, Yujgan
- Tan, Li
- Se, Yuj-Tsin
|
RU2825306C1 |
NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
COMBINED TREATMENT METHODS USING ALK INHIBITORS |
2015 |
- Lebvol Devid
- Peters Malte
- Li Nansin
- Lau I Yan
- Skott Dzheffri
|
RU2718914C2 |
ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION |
2018 |
- Surh, Charles D.
- Lee, Jun-Young
|
RU2745451C1 |
COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE |
2017 |
- Derouazi Madiha
- Belnoue Elodie
|
RU2769314C1 |
COMBINATION OF IMMUNE CHECKPOINT MODULATOR AND COMPLEX CONTAINING CELL-PENETRATING PEPTIDE, CARGO MOLECULE, AND TLR PEPTIDE AGONIST FOR MEDICAL USE |
2017 |
- Deruazi Madikha
- Belnu Elodi
|
RU2748378C2 |
COMBINATION |
2015 |
- Lyne, Paul, Dermot
- Mccoon, Patricia, Elizabeth
- Woessner, Richard
|
RU2744841C2 |
COMBINATION THERAPY OF ANTIBODY TO PROGASTRIN AND IMMUNOTHERAPY FOR CANCER TREATMENT |
2018 |
|
RU2784604C2 |
USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF MEDICINAL AGENT FOR TREATING SOLID TUMOURS |
2020 |
|
RU2825845C2 |
IMPROVED IMMUNE CELLS WITH DOUBLE shRNA AND COMPOSITIONS CONTAINING THEM |
2019 |
- Kim, Chan Hyuk
- Lee, Young-Ho
- Lee, Yujean
- Lee, Hyeongji
- Lee, Sang Hoon
|
RU2793922C2 |